Klebsiella pneumoniae genomic DNA

Klebsiella pneumoniae genomic DNA comprises the complete genetic material of the bacterium Klebsiella pneumoniae, a Gram-negative pathogen associated with numerous infections, especially in healthcare settings. The genome contains both core and accessory genes; the accessory genome confers virulence traits and antibiotic resistance. Genomic studies have revealed extensive genetic diversity among K. pneumoniae strains, including a large accessory genome that enables rapid adaptation and acquisition of resistance genes[3][5]. While individual genes or gene products (such as beta-lactamases, capsule synthesis enzymes, or metal transporters) within this DNA can be potential therapeutic targets, the entire genomic DNA itself is not used as a direct drug target or biomarker[3][5][1].\n\nKey points:\n- The term does not denote a discrete molecular entity amenable to specific pharmacological targeting.\n- The genome encodes a vast array of proteins, some of which (e.g., beta-lactamases, capsular polysaccharide synthesis enzymes, efflux pumps) are established therapeutic targets in K. pneumoniae[2][3][5].\n- Entry is too broad and thus not valid as a precise therapeutic target, protein, receptor, or actionable molecular entity.

Other names

K. pneumoniae genomeKlebsiella pneumoniae whole genome sequenceKlebsiella pneumoniae DNA